PICK1: a multi-talented modulator of AMPA receptor trafficking.

Abstract:

:AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor trafficking is a fundamental mechanism for regulating synaptic strength, and hence may underlie cellular processes involved in learning and memory. PICK1 (protein interacting with C-kinase) is a PDZ and BAR domain-containing protein that has recently emerged as a key regulator of AMPA receptor traffic. Via the PDZ domain, PICK1 interacts directly with AMPA receptor subunits and is involved in the regulated removal of AMPA receptors from the synaptic plasma membrane. PICK1 has the ability to functionally interact with a number of cellular processes, including calcium signaling, actin polymerisation and phospholipid membrane architecture. In this review, I summarize recent findings that describe the importance of PICK1 in neurons and its specific molecular characteristics that enable it to regulate AMPA receptor trafficking.

journal_name

Pharmacol Ther

authors

Hanley JG

doi

10.1016/j.pharmthera.2008.02.002

subject

Has Abstract

pub_date

2008-04-01 00:00:00

pages

152-60

issue

1

eissn

0163-7258

issn

1879-016X

pii

S0163-7258(08)00032-6

journal_volume

118

pub_type

杂志文章,评审
  • Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.

    abstract::In mediating the transfer of cholesteryl esters (CE) from antiatherogenic high density lipoprotein (HDL) to proatherogenic apolipoprotein (apo)-B-containing lipoprotein particles (including very low density lipoprotein [VLDL], VLDL remnants, intermediate density lipoprotein [IDL], and low density lipoprotein [LDL]), t...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2003.10.001

    authors: Le Goff W,Guerin M,Chapman MJ

    更新日期:2004-01-01 00:00:00

  • Perinatal changes in pulmonary vascular endothelial function.

    abstract::The pulmonary endothelium plays a crucial role in lung development and function during the perinatal period. Its 2 most important functions at this time are to help reduce pulmonary vascular resistance (PVR) in order to permit the entire cardiac output to pass through the lungs for the first time and to facilitate the...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.06.016

    authors: Wojciak-Stothard B,Haworth SG

    更新日期:2006-01-01 00:00:00

  • Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps.

    abstract::Since its commercial advent in 1985, transcranial magnetic stimulation (TMS), a technique for stimulating neurons in the cerebral cortex through the scalp, safely and with minimal discomfort, has captured the imaginations of scientists, clinicians and lay observers. Initially a laboratory tool for neurophysiologists s...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2011.09.003

    authors: Wassermann EM,Zimmermann T

    更新日期:2012-01-01 00:00:00

  • Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.

    abstract::Proteolytic degradation of unwanted proteins by the ubiquitin-proteasome system (UPS) is critical for normal maintenance of various cellular functions. Parkinson's disease (PD), one of the most prevalent neurodegenerative disorders, is characterized by prominent and irreversible nigral dopaminergic neuronal loss and i...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.04.001

    authors: Sun F,Kanthasamy A,Anantharam V,Kanthasamy AG

    更新日期:2007-06-01 00:00:00

  • Advances in small molecules promoting neurotrophic function.

    abstract::Nerve growth factor (NGF) and other members of the neurotrophin family are critical for the survival and differentiation of neurons and have been implicated in the pathophysiology of numerous disease states. Although the therapeutic potential of neurotrophins has generated much excitement over the past decade, inconve...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.03.005

    authors: Price RD,Milne SA,Sharkey J,Matsuoka N

    更新日期:2007-08-01 00:00:00

  • G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes.

    abstract::Islet function is regulated by a number of different signals. A main signal is generated by glucose, which stimulates insulin secretion and inhibits glucagon secretion. The glucose effects are modulated by many factors, including hormones, neurotransmitters and nutrients. Several of these factors signal through guanin...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.08.002

    authors: Winzell MS,Ahrén B

    更新日期:2007-12-01 00:00:00

  • Therapeutic options for 5-lipoxygenase inhibitors.

    abstract::5-Lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into leukotriene (LT) A(4) and 5-hydroperoxyeicosatetraenoic acid. LTA(4) can then be converted into LTB(4) by LTA(4) hydrolase or into LTC(4) by LTC(4) synthase and the LTC(4) synthase isoenzymes MGST2 and MGST3. LTB(4) is a potent chemoattractan...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2006.05.009

    authors: Werz O,Steinhilber D

    更新日期:2006-12-01 00:00:00

  • TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

    abstract::The understanding of renal fibrosis in chronic kidney disease (CKD) remains as a challenge. More than 10% of the population of developed countries suffer from CKD. Proliferation and activation of myofibroblasts and accumulation of extracellular matrix proteins are the main features of kidney fibrosis, a process in whi...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2015.10.003

    authors: Muñoz-Félix JM,González-Núñez M,Martínez-Salgado C,López-Novoa JM

    更新日期:2015-12-01 00:00:00

  • Environmental factors and developmental outcomes in the lung.

    abstract::The developing lung is highly susceptible to damage from exposure to environmental toxicants particularly due to the protracted maturation of the respiratory system, extending from the embryonic phase of development in utero through to adolescence. The functional organization of the lungs requires a coordinated ontoge...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2007.01.011

    authors: Kajekar R

    更新日期:2007-05-01 00:00:00

  • In utero drug therapy.

    abstract::Drug therapy directed toward the fetus would be intended for either treating a fetal disorder or improving the capacity for later intrauterine or postnatal adaptation. Most reported trials involve single cases or small numbers of fetuses receiving the drug transplacentally after the first trimester, but before attaini...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(93)90051-e

    authors: Rayburn WF,Payne GG Jr

    更新日期:1993-01-01 00:00:00

  • Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.

    abstract::The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine, and traditional C...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107587

    authors: Liu T,Luo S,Libby P,Shi GP

    更新日期:2020-09-01 00:00:00

  • Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology.

    abstract::Thromboxane A(2) (TXA(2)), an unstable arachidonic acid metabolite, elicits diverse physiological/pathophysiological actions, including platelet aggregation and smooth muscle contraction. TXA(2) has been shown to be involved in allergies, modulation of acquired immunity, atherogenesis, neovascularization, and metastas...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2008.01.001

    authors: Nakahata N

    更新日期:2008-04-01 00:00:00

  • Intracellular signaling pathways that regulate behavioral responses to ethanol.

    abstract::Recent evidence indicates that ethanol modulates the function of specific intracellular signaling cascades, including those that contain cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase A (PKA), protein kinase C (PKC), the tyrosine kinase Fyn, and phospholipase D (PLD). In some cases, the specific...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2005.07.004

    authors: Newton PM,Messing RO

    更新日期:2006-01-01 00:00:00

  • Targeting peroxisome proliferator-activated receptors: A new strategy for the treatment of cardiac fibrosis.

    abstract::Cardiac fibrosis is a pathogenic factor of many cardiovascular diseases (CVD), which seriously affects people's life, and health and causes huge economic losses. Increasing evidence has shown that peroxisome proliferator-activated receptors (PPARs) can regulate the progression of cardiac fibrosis. For the first time, ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107702

    authors: Lu Q,Guo P,Guo J,Ares I,Lopez-Torres B,Martínez-Larrañaga MR,Wang X,Anadón A,Martínez MA

    更新日期:2020-10-04 00:00:00

  • Calcitonin gene-related peptide: multiple actions, multiple receptors.

    abstract::Calcitonin gene-related peptide (CGRP) shows diversity both in its effects and its receptors. It is likely to have roles as a neurotransmitter, neuromodulator, local hormone and trophic factor. Its effects include rapid changes in neuronal activity, relaxation of many types of smooth muscle, actions on metabolism and ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(92)90036-y

    authors: Poyner DR

    更新日期:1992-01-01 00:00:00

  • PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders.

    abstract::Neurodegenerative diseases represent some of the most devastating neurological disorders, characterized by progressive loss of the structure and function of neurons. Current therapy for neurodegenerative disorders is limited to symptomatic treatment rather than disease modifying interventions, emphasizing the desperat...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107705

    authors: Jamwal S,Blackburn JK,Elsworth JD

    更新日期:2020-10-09 00:00:00

  • Clinical benefits and pharmacology of scutellarin: A comprehensive review.

    abstract::Stroke and myocardial infarction are among the most common causes of mortality and disability in the world. The ischemic injury underlying these illnesses is complex, involving intricate interplays among many biological functions including energy metabolism, vascular regulation, hemodynamics, oxidative stress, inflamm...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2018.05.006

    authors: Wang L,Ma Q

    更新日期:2018-10-01 00:00:00

  • Astroglial neurotrophic and neurite-promoting factors.

    abstract::Astroglial cells express neurotrophic and/or neurite growth-promoting factors, including (a) peptide growth factors (e.g. nerve growth factors, ciliary neuronotrophic factor, fibroblast growth factor), (b) neurotransmitters (such as glutamate, neuropeptide Y), (c) cell adhesion molecules (e.g. N-CAM) and (d) extracell...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(94)00047-7

    authors: Müller HW,Junghans U,Kappler J

    更新日期:1995-01-01 00:00:00

  • Serotonin receptors involved in antidepressant effects.

    abstract::The neurotransmitter serotonin (5-hdroxytryptamine; 5-HT) has been implicated in the pathophysiology and treatment of major depression since the serendipitous discovery of antidepressant drugs in the 1950s. However, despite the generalised use of serotonin-enhancing drugs, such as the selective serotonin reuptake inhi...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2012.09.006

    authors: Artigas F

    更新日期:2013-01-01 00:00:00

  • Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.

    abstract::Although the interaction between FUra and DP in HCT 116 cells is fairly complex, data from other investigators indicate that in cell lines in which inhibition of TS is growth limiting at relatively low concentrations of fluoropyrimidines, DP appears to augment the cytotoxicity of FUra and FdUrd by blocking the salvage...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(89)90084-3

    authors: Grem JL,Fischer PH

    更新日期:1989-01-01 00:00:00

  • Molecular and clinical aspects of apoptosis.

    abstract::Unwanted cells are removed by physiological cell death processes that are highly conserved throughout the animal kingdom. Physiological cell death plays an important role in development, tissue homeostasis and defence against viral infection and mutation. This review describes the molecular components that implement t...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(96)00098-8

    authors: Uren AG,Vaux DL

    更新日期:1996-01-01 00:00:00

  • Intracellular trafficking of integrins in cancer cells.

    abstract::Integrins are heterodimeric cell surface receptors, which principally mediate the interaction between cells and their extracellular microenvironments. Because of their pivotal roles in cancer proliferation, survival, invasion and metastasis, integrins have been recognized as promising targets for cancer treatment. As ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2013.05.007

    authors: Onodera Y,Nam JM,Sabe H

    更新日期:2013-10-01 00:00:00

  • Metabolic polymorphisms.

    abstract::Polymorphisms have been detected in a variety of xenobiotic-metabolizing enzymes at both the phenotypic and genotypic level. In the case of four enzymes, the cytochrome P450 CYP2D6, glutathione S-transferase mu, N-acetyltransferase 2 and serum cholinesterase, the majority of mutations which give rise to a defective ph...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(93)90053-g

    authors: Daly AK,Cholerton S,Gregory W,Idle JR

    更新日期:1993-02-01 00:00:00

  • Death the Fas way: regulation and pathophysiology of CD95 and its ligand.

    abstract::Apoptotic cell death mediated by the members of the tumor necrosis factor receptor family is an essential process involved in the regulation of cellular homeostasis during development, differentiation, and pathophysiological conditions. Among the cell death receptors comprising the tumor necrosis factor receptor super...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/s0163-7258(00)00096-6

    authors: Sharma K,Wang RX,Zhang LY,Yin DL,Luo XY,Solomon JC,Jiang RF,Markos K,Davidson W,Scott DW,Shi YF

    更新日期:2000-12-01 00:00:00

  • A review of stonefish venoms and toxins.

    abstract::Venoms from stonefish (genus Synanceja) have marked effects on the cardiovascular and neuromuscular systems and on vascular permeability; the venoms also exhibit haemolytic and hyaluronidase activity. Recently, a toxic protein, stonustoxin (SNTX), was purified from the venom of S. horrida: the primary lethal action of...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(94)90022-1

    authors: Gwee MC,Gopalakrishnakone P,Yuen R,Khoo HE,Low KS

    更新日期:1994-01-01 00:00:00

  • Market structure and conduct in the pharmaceutical industry.

    abstract::The pharmaceutical industry offers the world's population alleviation and cure from a variety of medical conditions, while also contributing to the economic performance of many countries. The potential importance of these characteristics have made the industry an area of intense debate, criticism and praise. This revi...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/0163-7258(95)00002-x

    authors: Craig AM,Malek M

    更新日期:1995-05-01 00:00:00

  • Regulation of GABA(A) receptor membrane trafficking and synaptic localization.

    abstract::Synaptic inhibition plays a key role in regulating neuronal excitability and information processing in the brain. The strength of synaptic inhibition is therefore an important determinant of both cellular and network activity levels in the central nervous system (CNS). gamma-aminobutyric acid type A (GABA(A)) receptor...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章

    doi:10.1016/j.pharmthera.2009.03.012

    authors: Arancibia-Cárcamo IL,Kittler JT

    更新日期:2009-07-01 00:00:00

  • Comparative effects of DHA and EPA on cell function.

    abstract::Fish oil supplementation has been reported to be generally beneficial in autoimmune, inflammatory and cardiovascular disorders. Most researchers have attributed these beneficial effects to the high content of omega-3 fatty acids in fish oil (FO). The effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2009.01.004

    authors: Gorjão R,Azevedo-Martins AK,Rodrigues HG,Abdulkader F,Arcisio-Miranda M,Procopio J,Curi R

    更新日期:2009-04-01 00:00:00

  • Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities.

    abstract::The coronavirus disease 2019 (COVID-19) pandemic is caused by a newly emerged coronavirus (CoV) called Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). COVID-19 patients with cardiovascular disease (CVD) comorbidities have significantly increased morbidity and mortality. The use of angiotensin-converting ...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2020.107628

    authors: Wang JJ,Edin ML,Zeldin DC,Li C,Wang DW,Chen C

    更新日期:2020-11-01 00:00:00

  • Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future.

    abstract::The past three decades have witnessed a welcome expansion of the therapeutic armamentarium for the management of pulmonary arterial hypertension (PAH). However, against this backdrop, there have been some notable disappointments in drug development. Here we use these as case studies to emphasize the importance of info...

    journal_title:Pharmacology & therapeutics

    pub_type: 杂志文章,评审

    doi:10.1016/j.pharmthera.2016.04.012

    authors: Lythgoe MP,Rhodes CJ,Ghataorhe P,Attard M,Wharton J,Wilkins MR

    更新日期:2016-08-01 00:00:00